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Abstract
Background: Reports of inappropriate medication use are widespread. There is a growing literature detailing abuse
of drugs not typically thought to have high abuse liability. Melatonin is considered to be generally safe and is
categorized by the Food and Drug Administration as a nutritional supplement. There are no known reports of
intravenous melatonin abuse in the medical literature.
Case presentation: The authors report a case of a patient injecting melatonin with euphoric and then sedative
effects leading to two episodes of infective endocarditis culminating in aortic valve replacement.
Conclusion: Infective endocarditis continues to be a major potential complication of intravenous drug abuse. The
proliferation of novel street drugs, resurgence in the use of older drugs and ongoing abuse of medications warrant
continued research and vigilance in treating substance use disorders and attendant medical complications.
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Background
The changing landscape of drug use, including contin-
ued innovation of street drugs [1], intravenous injection
of tablets meant for oral ingestion [2] and a changing
demographic and resurgence in abuse of older drugs
such as heroin [3], present a continuing challenge to
healthcare teams. Prescription opioid and benzodiazep-
ine abuse is a widely known problem but there is a
growing literature describing abuse of medications that
are not conventionally considered to have high abuse
liability including several types of antidepressants [4].
Intravenous injection of tablets can lead to complica-
tions such as infective endocarditis (IE), stroke and a
variety of pulmonary pathology [5].
We report a case of a patient injecting melatonin
tablets leading to IE initially with Granulicatella adia-
cens and subsequently with Streptococcus salivarius (viri-
dans) necessitating aortic valve replacement. Melatonin
is thought to be generally safe and is categorized by the
FDA as a dietary supplement. It is a neurohormone
produced by the pineal gland and thought to be import-
ant in the maintenance of the sleep-wake cycle. It is
most commonly used for general sleep disorders, jet lag
and other circadian rhythm disorders and has also been
reported to have cytostatic action on some human can-
cers at doses typically between 1.5 mg and 10 mg at
night with variable efficacy. Common side effects include
fatigue, somnolence and hypothermia. There are no
known absolute contraindications to its use but caution
is advised with hepatic or renal impairment or immune
disorders [6]. It has not been reported to have high
abuse liablity, nor reported to cause euphoria. To our
knowledge this is the first report of its kind in the
literature.
Case presentation
Mr. S is a 58-year-old gentleman with a complicated
medical history including recurrent pulmonary embol-
ism related to antiphospholipid syndrome (APS), pul-
monary arteriovenous malformation, major depression
with two prior deliberate overdose attempts and remote
intravenous drug abuse (IVDA). He initially presented to
a community hospital following a motor vehicle accident
after new onset seizures and was found to have a small
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intraparenchymal brain hemorrhage. Anticoagulation
was held and he recovered with no long-term neurologic
sequelae.
One month later he was admitted to inpatient medi-
cine with suicidal ideation and hyponatremia, stabilized
and transferred to psychiatry. Later exam revealed a
weight increase of 2.3 kg over a 48 h period along with
low grade fever, new systolic and diastolic murmurs, sig-
nificant bilateral lower extremity edema and recurrence
of hyponatremia. Blood cultures grew Granulicatella
adiacens and trans-esophageal echocardiogram showed
aortic valve vegetations and moderate to severe regurgi-
tation. He was treated for endocarditis with penicillin
and gentamicin. The infection was attributed to poor
dentition (Mr. S adamantly denied any IVDA) and three
teeth were extracted. He was referred for valve replace-
ment but this was postponed due to concern over bleed-
ing risk.
Over the next several months, Mr. S. had multiple ad-
missions to inpatient psychiatry for suicidality and a
medical admission for pulmonary embolism and worsen-
ing biventricular heart failure. He was referred again for
valve replacement.
Prior to surgery he presented with increasing malaise,
fevers and chills. Blood cultures grew Streptococcus sali-
varius (viridans) and examination showed worsening
heart failure, mitral and aortic insufficiency murmurs,
splinter hemorrhages on two fingers and a Janeway le-
sion on the left distal forearm. Additionally, he had a
palpable venous cord with overlying injection marks on
the right lateral wrist. Echocardiogram showed aortic
valve endocarditis with mobile vegetation (Fig. 1) and se-
vere regurgitation. He was treated with targeted intra-
venous antibiotics.
During this admission Mr. S reported he had been
crushing single 5 mg tablets of melatonin, mixing with
ice water and injecting intravenously several times per
week, up to two times per day for the past two years. He
confirmed this history on psychiatric consultation and
added that he now had a sense of relief about having “a
clean slate, no more secrets.” Mr. S. described an initial
euphoric effect with melatonin injection. This dimin-
ished but he continued injecting to help initiate sleep.
Mr. S underwent aortic valve replacement a week after
he disclosed to staff his abuse of melatonin. Of note, he
had only one psychiatric hospitalization in the nine
months subsequent to his valve replacement compared
with six inpatient psychiatric admissions in the year
prior to his surgery.
Discussion
Melatonin is thought to be generally safe with no re-
ported abuse liability and its prescription drug counter-
part, ramelteon, a melatonin receptor agonist, is also
thought to have low to no abuse potential [7]. Intraven-
ous injection of any substance, however, places individ-
uals at risk for infectious and embolic complications and
continues to be a source of worldwide medical and pub-
lic health attention [8]. Mr. S’s complications from mela-
tonin injection included recurrent aortic valve
endocarditis and we hypothesize that his initial stroke
may have been due to tablet material traveling through
his known pulmonary arteriovenous malformation.
These types of embolic phenomena have been reported
with injection of other types of tablets [9]. It must be
noted that his recurrent endocarditis was most likely re-
lated to injection habits and nonsterile technique as op-
posed to any melatonin-specific characteristics.
IE remains a serious illness with high morbidity and
mortality [10]. Its approximate incidence is 3 to 9 cases
per 100,000 in industrialized nations. The precise inci-
dence of IE in IVDA is not known but remains
Fig. 1 Echocardiogram showing mobile aortic valve vegetation
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problematic [8]. It is estimated that up to 41 % of IVDA
patients with bacteremia will develop IE [11].
Offending organisms in IE are most often streptococci
and staphylococci [12]. IE caused by Granulicatella
adiacens is thought to be a rare but increasingly fre-
quent cause and can be associated with severe cases of
bacteremia regardless of prior immune state. A case
series and literature review from early 2015 identified
only 29 published cases of IE due to G. adiacens and in-
fection carried a 17% mortality rate. Forty-four percent
of cases involved the aortic valve [13].
Conclusions
We report the first known case of recreational melatonin
injection leading to IE with Granulicatella adiacens and
subsequently with Streptococcus salivarius (viridans) ne-
cessitating aortic valve replacement. IE continues as a
major potential complication of IVDA. The proliferation
of novel street drugs, resurgence in the use of older
street drugs and ongoing abuse of prescribed medica-
tions and dietary supplements warrant continual re-
search and vigilance in treating substance use disorders
and attendant medical complications.
Consent
Written consent for publication in the medical literature
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